Barriers to access to hepatitis C treatment
نویسندگان
چکیده
منابع مشابه
Barriers to Hepatitis C Treatment among Women in Methadone Treatment: A Study from Iran, the Most Populous Persian Gulf Country
Background: Untreated Hepatitis C Virus (HCV) has been reported among many Iranian female methadone patients. However, few of them report receiving HCV treatment. The present study is the first research from western Asia that explored the barriers to receiving HCV treatment among a group of Iranian female HCV-infected methadone patients.Methods: This qualitative study was conducted in four main...
متن کاملBarriers to Treatment Access for Chronic Hepatitis C Virus Infection: A Case Series.
Restrictive policies on access to new, curative hepatitis C treatments represent a substantial barrier to treating patients infected with hepatitis C. This case series demonstrates challenges experienced by patients and practitioners in accessing these treatments and highlights several strategies for navigating the treatment preauthorization process.
متن کاملBarriers to starting and completing hepatitis C treatment
The treatment of hepatitis C, generally with the antiviral agents pegylated interferon and ribavirin, is associated with a significant risk of adverse side effects, such as the suppression of bone marrow production, anaemia, depression and other mood disorders, fatigue and nausea, which lead approximately 14% of recipients to discontinue treatment (Manns et al., 2001). Ribavirin may lead to bir...
متن کاملAccess to hepatitis C medicines
Hepatitis C is a global epidemic. Worldwide, 185 million people are estimated to be infected, most of whom live in low- and middle-income countries. Recent advances in the development of antiviral drugs have produced therapies that are more effective, safer and better tolerated than existing treatments for the disease. These therapies present an opportunity to curb the epidemic, provided that t...
متن کاملOvercoming barriers to care for hepatitis C.
* Data in the column on mortality are from the Centers for Disease Control and Prevention, National Center for Health Statistics, Multiple Cause of Death 1999–2009 (http://wonder.cdc.gov/mcd-icd10.html), and are based on hepatitis C infection (ICD-10, 17.1 and 18.2) declared as a contributing cause on the death certificate; data in the columns on transplantation are from the Organ Procurement a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Infection in Developing Countries
سال: 2016
ISSN: 1972-2680
DOI: 10.3855/jidc.7849